Clinical Trial Update: Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating decitabine and midostaurin in older adults with newly diagnosed acute myeloid leukemia; study status terminated with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Midostaurin (midostaurin)

Snippet

Sponsor: David Iberri | Conditions: Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23 (MLL) Abnormalities | Phase 2 | Status: TERMINATED | Results posted: 2018-09-07